Experimental targeted radioiodide therapy following transfection of the sodium iodide symporter gene: Effect an clonogenicity in both two-and three-dimensional models
S. Carlin et al., Experimental targeted radioiodide therapy following transfection of the sodium iodide symporter gene: Effect an clonogenicity in both two-and three-dimensional models, CANC GENE T, 7(12), 2000, pp. 1529-1536
To evaluate the potential of the expression of the sodium/iodide symporter
(NIS) as a means of targeting radioiodine to tumor cells, we have employed
plasmid-mediated transfection of the NIS gene into a range of mammalian cel
l hosts. We observed perchlorate-inhibitable iodide uptake up to 41 fold ov
er control in all NIS-transfected cells. We assessed the effect of NIS expr
ession followed by exposure to I-131- on the clonogenic survival of UVW gli
oma cells. After exposure of two-dimensional monolayer cultures of UVW-NIS
culls to I-131- at a radioactive concentration of 4 MBq/mL, clonogenic surv
ival was reduced to 21%. Similar treatment of UVW-NIS cells in three dimens
ional spheroid cultures resulted in a reduction of clonogenic survival to 2
.5%. This increase in sensitivity to I-131 exposure is likely to be due to
a radiological bystander effect. These results are very Encouraging for the
development of a novel cytotoxic gene-therapy strategy in which a radiolog
ical bystander effect plays a significant role in tumor cell sterilization.